VSM stands for vascular smooth muscle, the specialized muscle tissue lining your blood vessels that controls how wide or narrow those vessels are at any given moment. By adjusting vessel diameter, VSM directly regulates blood pressure and determines how much blood reaches each organ. It’s found in the walls of arteries, arterioles, and veins throughout your body, and its dysfunction is central to conditions like hypertension, atherosclerosis, and pulmonary arterial hypertension.
Where VSM Sits in Your Blood Vessels
Blood vessel walls have three layers, and VSM cells are concentrated in the middle layer, called the tunica media. In arteries and arterioles, this layer is thick and muscular, giving these vessels the ability to squeeze down or open up in response to signals from the nervous system, hormones, and chemicals released by nearby cells. Veins, by contrast, have a relatively thin muscle layer, which is why most of the resistance to blood flow comes from the arterial side of the circulation.
Unlike the skeletal muscle you use to move your arms and legs, smooth muscle works involuntarily. You don’t consciously decide to tighten your blood vessels. VSM cells exist in a state of partial, ongoing contraction called “tone,” and they adjust that tone up or down depending on what your body needs. During exercise, vessels supplying your muscles relax to deliver more blood. When you’re cold, vessels near your skin tighten to conserve heat. This constant, automatic fine-tuning is what keeps blood pressure stable and organs properly supplied.
How VSM Contracts and Relaxes
VSM contraction begins with calcium. When a cell receives a signal to contract, calcium floods into the cell from two sources: storage compartments inside the cell and the fluid outside the cell. Normally, calcium levels inside the cell are kept very low, so even a small influx creates a big change. That calcium binds to a helper protein called calmodulin, and the resulting pair activates an enzyme that triggers the cell’s internal fibers to slide against each other and shorten, just like a rope being pulled taut. The vessel narrows.
Relaxation is essentially the reverse. When calcium gets pumped back out of the cell or into storage, the contraction machinery disengages, and the vessel widens. This is exactly how one of the most common classes of blood pressure medications works: calcium channel blockers prevent calcium from entering VSM cells through specific channels on the cell surface, keeping vessels relaxed and lowering blood pressure.
VSM’s Role in Blood Pressure
Blood pressure is determined by two things: how hard the heart pumps and how much resistance the blood encounters as it flows through vessels. VSM is the primary controller of that resistance. When VSM cells throughout the body contract, vessel diameters shrink, resistance goes up, and blood pressure rises. When they relax, the opposite happens.
Several hormonal systems act directly on VSM to manage this process. The renin-angiotensin system, for example, produces a hormone called angiotensin II that signals VSM cells to tighten up, particularly in the small arteries supplying the kidneys. Adrenaline and related stress hormones activate receptors on VSM cells that also promote contraction. On the relaxation side, the inner lining of blood vessels (the endothelium) produces nitric oxide, a gas that diffuses into neighboring VSM cells and triggers a signaling cascade that relaxes them. This nitric oxide pathway is one of the body’s most important mechanisms for keeping vessels open and blood flowing smoothly.
When nitric oxide production is impaired, whether from aging, diabetes, oxidative stress, or chronic high blood pressure, VSM cells lose a key relaxation signal. This contributes to the stiff, constricted vessels seen in people with hypertension and cardiovascular disease.
What Happens to VSM in Disease
In chronic high blood pressure, VSM cells don’t just work harder. They physically remodel the vessel wall. In large arteries, the cells grow larger (a process called hypertrophy), thickening the vessel wall by 15 to 40 percent. This makes the arteries stiffer, which raises pulse pressure and forces the heart to work harder. In smaller resistance arteries, the remodeling is different: cells rearrange themselves inward, narrowing the vessel’s internal opening without necessarily adding new material. The result is higher resistance to blood flow, which perpetuates the cycle of high blood pressure.
In people who have both hypertension and diabetes, or in pulmonary hypertension, the remodeling tends to be more aggressive, with VSM cells both enlarging and multiplying to produce a thicker vessel wall.
Phenotypic Switching and Atherosclerosis
One of the most important discoveries about VSM in recent decades is that these cells can fundamentally change their identity. In a healthy vessel, VSM cells are in a “contractile” state: they’re elongated, packed with the protein fibers needed for contraction, and focused entirely on regulating vessel diameter. But in response to injury, inflammation, or low oxygen, VSM cells can switch to a “synthetic” state. In this mode, they flatten out, lose their contractile machinery, and start pumping out inflammatory chemicals and enzymes that break down surrounding tissue.
This switch is a major driver of atherosclerosis, the buildup of fatty plaques inside arteries. Genetic tracing studies have shown that roughly 70 percent of VSM cells found inside atherosclerotic plaques originated from normal contractile cells in the vessel wall that underwent this transformation, migrated into the plaque, and began contributing to its growth. These transformed cells produce less of the contractile proteins that define healthy VSM and more of the molecules associated with inflammation and tissue breakdown.
How Medications Target VSM
Because VSM plays such a central role in blood pressure and vascular disease, several major drug classes work by acting directly on these cells. Calcium channel blockers are the most straightforward example. They block the main calcium channel on VSM cell surfaces, preventing the calcium influx that drives contraction. With less calcium entering the cells, vessels stay more relaxed, and blood pressure drops. These medications are among the most widely prescribed treatments for hypertension and angina.
Other drug classes take indirect routes to the same goal. Some medications enhance the nitric oxide relaxation pathway. Others block the receptors that adrenaline or angiotensin II use to trigger VSM contraction. In emergency settings, drugs that activate adrenaline receptors on VSM can be used to rapidly raise blood pressure when it falls dangerously low, by forcing widespread vessel constriction.
The growing understanding of phenotypic switching has also opened new avenues for treating atherosclerosis. If researchers can find ways to prevent VSM cells from abandoning their contractile identity, or to push synthetic cells back toward a contractile state, it could slow or even reverse plaque formation in arteries.